Triazolyl aminopyrimidine compounds
US8063035B2 · kind B2 · utility
1Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 7, 2008 |
| Grant date | Nov 22, 2011 |
| Priority date | — |
| Expiry date | Aug 6, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides triazolyl aminopyrimidine compounds useful in the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.